Christine Ballard

Assistant Professor of Public Health


585.594.6209
Ballard_Christine@roberts.edu

Biography:

Christine Ballard is an Assistant Professor of Public Health in the School of Business. Christine is trained as an epidemiologist and brings more than 10 years of experience in healthcare research and education. She received her Master of Public Health with a concentration in Biomedical Science from SUNY University at Albany. After graduating, Christine joined the University of Rochester Medical Center’s Department of Neurosurgery where she served as a musculoskeletal outcomes health service researcher evaluating the effects of coverage and reimbursement policy on utilization and outcomes. Most recently, Christine was Director of Education and Informatics for Pandion Optimization Alliance.

Research Interests: Global Health, Cancer Epidemiology, Health Disparities and Social Determinants of Health.

Publications:

Pittman, CA., Miranpuri, A. Neurosurgery clinical registry data collection utilizing Informatics for Integrating Biology and Bedside and Electronic Health Record at the University of Rochester. Neurosurgery Focus; 39(6): E16.

Markman, J., Gewandter, J., Frazer, M., Pittman, C., Cai, X., Jahromi, B., Dworkin, R., Burke, L., Farrar, J. Evaluation of outcome measures for Neurogenic Claudication associated with Lumbar Spinal Stenosis: A patient-centered approach. Neurology; 85(14):1250-1257.

Hemminger, LE., Pittman, CA., Korones, DN., Serventi, J., Ladwig, S., Holloway, R. Palliative and End of Life Care in Glioblastoma: Defining and Measuring Opportunities to Improve Care. Neuro-oncology Practice. DOI:10.1093/nop/npw022

Hemminger L, Pittman C, Mohile N. Caregiver time burden in newly diagnosed glioblastoma: a prospective analysis. J Clin Oncol. 2016;34(suppl 26S; abstr 242).

Liu Y, Pittman C, Richardson M, Mohile N, Milano M, Usuki  K, Walter K. PDCT-14. Chemotherapy Benefits Some but not all High Grade Glioma Patients. Neuro-Oncology. 2016;18(suppl 6.)

Liu Y, Pittman C, Richardson M, Mohile N, Milano M, Usuki  K, Walter K. HCP-16. Population-based survival rates from high grade glioma (HGG) are not improved by increased chemotherapy use. Neuro-Oncolology. 2016;17(suppl 5):v104-v105.